P eriodontitis is a chronic inflammatory and infectious disease characterized by the interaction between periodontal tissue and periodontopathogenic bacteria such as Porphyromonas gingivalis (1) . Such Gram-negative bacteria are known to produce pathogenic factors, such as outer membrane protein (Omps), leukotoxin, and protease, to induce inflammation in gingival tissue (2) . These bacteria also possess lipopolysaccharide (LPS) in the outer membrane as a modulator of inflammation (3) . The immune response to periodontopathogenic bacteria plays an essential role in the breakdown of connective tissue and alveolar bone (4, 5) . Gingival fibroblasts, the major component of periodontal connective tissue, are involved in the inflammatory processes in response to bacterial challenge. In particular, gingival fibroblasts produce proinflammatory cytokines, including IL-1b, IL-6, IL-8 and TNF-a (6, 7). These cytokines produced from gingival fibroblasts are involved in the activation of monocytes, macrophages, dendritic cells, neutrophils and lymphocytes (8) . As a consequence of upregulation of acquired cellular immune responses caused by fibroblast-derived proinflammatory cytokines, the progression of periodontal disease is promoted (8) .
IL-32, a recently characterized cytokine, has six isoforms and is produced by natural killer (NK) cells, T-cells, epithelial cells and monocytes (9Á11). IL-32 is also upregulated in response to TNF-a and IL-1b in inflammatory bowel disease, Crohn's disease and rheumatoid arthritis (12, 13) . Therefore, it is thought that IL-32 functions as a proinflammatory cytokine. Since IL-32 is involved in the upregulation of the proinflammatory cytokine production in some diseases, it was hypothesized that IL-32 might also be associated with periodontal disease by upregulation of proinflammatory cytokines. Therefore, in this study, the expression of IL-32 in healthy subjects and in the inflamed periodontal tissue collected from patients was compared. The expression patterns of IL-32 were then analyzed in cultured human gingival fibroblasts (HGF). The effect of IL-32 on the proinflammatory cytokine expression by HGF was also investigated.
Materials and methods
Collection of human gingival tissue samples After obtaining approval from the Ethical Committees of The Forsyth Institute and Harvard School of Dental Medicine (HSDM, Boston, MA, USA), both healthy and inflamed gingival tissue samples were collected in the Periodontology Department laboratories at HSDM. Healthy gingival tissue was characterized by the lack of bleeding on probing (gingival pocket depth53 mm; n0 5, 2 males and 3 females, aged 29Á43 years) and collected from the healthy volunteer who signed informed consent prior to enrollment. Periodontal disease was divided into three categories by the degree of swelling of the site collected from the patients. Since there was a limitation among the small number of samples to discuss the correlation between the production of IL-32 and three different categories, these were all grouped as one category 'inflamed'. Inflamed gingival tissues were obtained from patients with periodontal disease at flap surgery. The periodontally diseased sites of patients who donated the gingival tissue samples were also characterized by radiological bone resorption and bleeding on probing (gingival pocket depth ]5 mm; n 07, 4 males and 3 females, aged 20Á55 years) ( Table 1) .
Cell culture
Human gingival fibroblasts (HGF) were obtained from healthy volunteers as described previously (14) . HGF were cultured to confluence in a 35 mm diameter dish with Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (GIBCO, Grand Island, NY, USA), 100 units/ml penicillin, 100 mg/ml streptomycin and 1 mg/ml amphotericin B. When HGF cells formed a confluent monolayer, cells were harvested with 0.05% trypsin and 0.02% EDTA and transferred to a 100 mm diameter plastic culture dish. Fourth passage HGF cultures were used in the following experiments.
Detection of interleukin-32 and IL-8 by enzymelinked immunosorbent assay (ELISA) In order to examine the production of IL-32 in the gingival tissue, gingival tissues were homogenized in lysis buffer (15) . IL-32 from the gingival tissue homogenate or 
Immunofluorescent microscopic observation
Frozen sections of each tissue (two healthy and three inflamed tissues) were fixed with Acetone-alcohol at 48C for 1 min. After blocking with 0.5% BSA in PBST, each section was incubated with anti-IL-32 mouse monoclonal antibody (2 mg/ml, #513501; BioLegend) or anti-IL-8 mouse monoclonal antibody (2 mg/ml, #500-M8; Peprotech) in PBS at 48C for 12 hours. Then, Alexa594-labeled anti-mouse IgG (Invitrogen, Carlsbad, CA, USA) was applied for 30 min at room temperature. The Alexa594 signals in the sections were observed using fluorescent microscopy (model BZ-9000; Keyence, Osaka, Japan).
Stimulation of HGF
The confluent culture of HGF was stimulated with formalin fixed P. gingivalis W83 (10 7 CFU/ml) for 12 hours to examine the expression of mRNA and for 24 hours to detect the production of IL-32 or IL-8 by ELISA.
Real-time PCR analysis
After the stimulation of HGF, total RNA was purified and analyzed by the two-step LightCycler † 480 RealTime PCR System (17) . Briefly, one microgram of total RNA was used for reverse transcription by the First Strand cDNA Synthesis Kit for RT-PCR (Roche Diagnostics, Tokyo, Japan). Then, one microliter of cDNA was used for real-time PCR. The amplified condition was described previously (17) . The primers used in this study are listed in Table 2 .
Statistical analysis
Differences between the two groups were analyzed by Student's t-test.
Results
Detection of IL-32 and IL-8 in human gingival tissue homogenate The production of total IL-32 in human healthy or inflamed gingival tissues was examined by ELISA (Fig. 1A) . Although IL-32 was detected in both healthy and inflamed tissues, the amount of IL-32 in the inflamed gingival tissue was lower than that observed in the healthy tissue (average healthy tissue: 471.69108.7 pg/mg tissue; inflamed tissue: 106.1969.7 pg/mg tissue). Proinflammatory cytokine IL-8 production in the gingival tissues was also measured by ELISA (Fig. 1B) . The amount of IL-8 in periodontally diseased tissue was higher than in healthy gingival tissue (average healthy tissue: 38.6911.4 pg/mg tissue; inflamed tissue: 840.59 513.6 pg/mg tissue), suggesting that the gingival tissues sampled from patients with periodontal disease were inflamed. Immunohistostaining of IL-32 showed the presence of many positively stained cells in the healthy gingival tissue section (Fig. 1C) . In particular, prickle and basal cell layers in the epithelium and fibroblastic cells in connective tissue were heavily stained. On the other hand, there were fewer positive cells in the inflamed gingival tissue (Fig. 1D) . Neither healthy nor diseased gingival tissue was stained in the control non-immunized mouse IgG (Fig. 1E, F) . On the other hand, the production of IL-8 in healthy tissue was weak, whereas positive staining of IL-8 expression was found in the inflamed gingival tissues, especially epithelium and connective tissue (Fig. 1G, H) . Fig. 2A) . A similar result was obtained in the total IL-32 production at the protein level in the HGF culture supernatant (66% reduction) (Fig. 2B) .
The effect of IL-32 on expressions of IL-8 mRNA in HGF In an attempt to examine the anti-inflammatory effect of IL-32, recombinant IL-32g was added into the HGF culture with or without fixed P. gingivalis. Bacterial stimulation induced the mRNA expression of IL-8 (Fig. 2C) . However, the addition of IL-32g resulted in the suppression of IL-8 mRNA expression (66% reduction). Furthermore, anti-IL-32 goat IgG partially reversed the suppression of IL-8 mRNA caused by P. gingivalis. Interestingly, recombinant IL-32g alone without P. gingivalis also showed inhibitory effect on IL-8 mRNA expression in HGF (35% reduction). Finally, anti-IL-32 neutralizing antibody upregulated IL-8 mRNA expression in the non-stimulated HGF, indicating that constitutively expressed IL-32 appeared to suppress IL-8 mRNA expression. These results suggested that IL-32 may play a role in the downregulation of IL-8 mRNA expression in HGF and that the periodontal pathogen P. gingivalis can suppress IL-32 production from HGF.
Discussion
In this study, we investigated the production pattern of IL-32 in periodontal tissue with or without periodontal disease. The production of IL-32 was lower in the tissue from periodontitis patients compared with the tissue of healthy volunteers (Fig. 1 ). An in vitro study showed that IL-32 was constitutively expressed in HGF, but suppressed by P. gingivalis stimulation. Recombinant IL-32g exhibited an anti-inflammatory effect by suppressing the IL-8 expression in HGF stimulated with P. gingivalis. Furthermore, antibody-mediated neutralization of IL-32 in non-stimulated HGF increased IL-8 production. Taken together, these results suggested that IL-32 appeared to play an anti-inflammatory role in healthy gingival tissue, while suppression of IL-32 by the periodontal pathogen P. gingivalis may lead to the upregulation of inflammatory response, which promotes the progression of periodontal disease.
Previous reports show that IL-32 was originally cloned as a transcript (NK4) that is produced in NK-or T-cells (11) . In addition, IL-32 is produced by mononuclear, endothelial and epithelial cells after stimulation by IL-1b, IL-2, IL-18, TNF-a or IFN-g (9, 18Á20). DNA microarray analysis shows that P. gingivalis-derived LPS induced the expression of IL-32 in monocytes (THP-1 cells) (3). However, very little is known about the expression of IL-32 in the gingival fibroblasts which constitute majority of tissue supporting cells in lamina propria of periodontal tissue. Immunohistochemistry showed strong staining patterns in subgingival fibroblastic cells as well as gingival epithelial cells (Fig. 1C, D) , and such expression of IL-32 in the gingival tissue was lower in the diseased gingival tissue compared with the healthy ones (Fig. 1A) . Although some cytokines are known to be influenced by genetic background or singlenucleotide polymorphism (SNP), the small number of subjects used in this study is not suitable to compare the correlation between healthy and periodontitis tissue (21) . Furthermore, the production of IFN-g and IL-13 in whole blood cell from smokers is reported to be higher than non-smoker (22) . Therefore, it is very significant to analyze the production of IL-32 in many subjects including multiple genetic background. Our in vitro experiment showed that the addition of P. gingivalis suppressed the otherwise constitutively expressed IL-32 mRNA and protein in HGF ( Fig. 2A, B) . These results indicated that down-regulatory effects of IL-32 on inflammatory response can be interrupted by periodontal pathogen, P. gingivalis, in the context of periodontal disease.
It has been reported that the production of IL-32 is increased in rheumatoid arthritis (RA), an inflammatory bone resorptive disease, which shares several pathogenic characteristics in common with periodontal disease (23) . Therefore, these results were unexpected. However, one of the major differences between RA and periodontal disease is the phenomenon of polymicrobial infection. A number of virulent factors are reported to be produced from periodontal pathogens such as P. gingivalis (24Á26). Therefore, it is plausible that some bacterial factors, including LPS, outer membrane protein, and protease, might have acted on HGF and suppressed IL-32 production by generating a negative signal to reduce IL-32 mRNA expression. On the other hand, IL-32b has been reported to induce the production of anti-inflammatory cytokine IL-10 (27). More specifically, IL-32 was found to promote the expression of IL-10 in monocyte linage cells upon stimulation with phorbol 12-myristate 13-acetate (PMA) or lipopolysaccharide (LPS) (27) . While immune cells are accepted as the major cellular source of IL-10 in the context of inflammation (28, 29) , it is also true that HGF produce IL-10 in response to bacterial challenge (30) . Therefore, it is conceivable that IL-10 may intervene in the bacteria-mediated suppression of IL-32 production from HGF.
Our in vivo and in vitro results showed that IL-32 is produced constitutively in healthy conditions. Hence, it was hypothesized that IL-32 might have an anti-inflammatory effect in periodontal tissue. IL-8 is a chemokine produced by gingival epithelial cells and upregulated in the presence of periodontopathogenic bacterial stimulation (31) . IL-8 induces the chemoattraction of neutrophils through CXCR1 receptors in the affected lesion, which, in turn, promote inflammatory response by such tissue destructive factors as reactive oxygen species (ROS) from migrating neutrophils (32) . Recombinant IL-32g suppressed the induction of IL-8 mRNA in HGF, while anti-IL-32 antibody neutralized the effect of IL-32. Furthermore, the addition of anti-IL-32 antibody into HGF culture without P. gingivalis increased IL-8 mRNA. Thus, IL-32 may function as an autocrine factor to downregulate the expression of IL-8.
It is curious that a putative receptor for IL-32 remains unknown. To date, the only identified IL-32 binding protein is proteinase 3 (PR3) whose catalytic activity partially cleaves IL-32, increasing bioactivity of IL-32 (33) . The difficulty of identifying an IL-32 receptor was speculated to result from its possibly high molecular weight which is not feasibly separated in SDS-PAGE. Alternatively, the binding affinity of IL-32 could be lower than PR3 (33) which is not suitable for affinity-dependent isolation. However, based on the contrary results between present study and the report of RA (3, 13) , two different types of IL-32 receptors can be assumed to induce cell signaling; one type of receptor induces a proinflammatory signal, while another induces an anti-inflammatory signal. Based on the results of this study, it can be hypothesized that HGF express IL-32 that has a receptor of the second type. This theory, however, requires further study to identify the HGF-specific IL-32 receptor and to characterize the properties of the cell signaling elicited by the IL-32 receptor expressed on HGF.
In conclusion, since constitutive production of IL-32 can inhibit IL-8 production, IL-32 might play an important role in regulating inflammation in healthy gingival tissue. On the other hand, it was found that periodontopathogenic bacterial challenge can suppress IL-32 production, leading to the increase of inflammatory response by loss of anti-inflammatory IL-32. Taken together, these findings could help to further define the etiology of periodontal disease, as well as form a basis for novel therapeutic regimens against periodontitis. Further study will be needed to determine the target molecule of IL-32 in periodontitis and the structural component of P. gingivalis that suppresses IL-32 expression.
